» » »

Tips for Women at High Risk for Breast Cancer Boston MA

Worries about side effects are a major reason why only 6 percent of American women at high risk for breast cancer are willing to take the drug tamoxifen to prevent the disease, a new study finds.

Recreation Chiropractic
(617) 678-7888
224 Clarendon Street Suite 32
Boston, MA

Data Provided by:
Robert Oates, MD
(617) 638-8485
720 Harrison Ave
Boston, MA
Business
Boston University Medical Center Urologists
Specialties
Urology

Data Provided by:
Diane E Krause, MD
(617) 636-3271
260 Tremont St
Boston, MA
Business
New England Medical Center Internal Medicine
Specialties
Internal Medicine

Data Provided by:
Boston Copley Square Chiropractic - Boston
(617) 206-9933
304 Columbus Ave
Boston, MA

Data Provided by:
Lena Adams
(617) 247-5998
352 Newbury St, Boston
Boston, MA
Business
Lena Adams Practice
Specialties
Ophthalmology, Macular Degeneration diagnosis and cure, Post-accident surgery
Insurance
Medicare Accepted: Yes
Accepts Uninsured Patients: Yes
Emergency Care: Yes

Doctor Information
Medical School: Harvard University, 1989
Additional Information
Languages Spoken: English,Spanish,Icelandic,French

Data Provided by:
Brian J Awbrey MD
(617) 726-3808
151 Merrimac St
Boston, MA
Specialties
Orthopedics

Data Provided by:
Diamond Chiropractic
(617) 262-2225
224 Clarendon Street
Boston, MA

Data Provided by:
James W May Jr. MD
(617) 726-8220
15 Parkman St, STE 435
Boston, MA
Specialties
Cosmetic Surgery

Data Provided by:
Arthur L Day, MD
(617) 732-6810
45 Francis St
Boston, MA
Business
Brigham & Women's Hospital Neurosurgery
Specialties
Neurology

Data Provided by:
Ajay D Wasan, MD
(617) 732-8510
75 Francis St
Boston, MA
Business
Brigham & Women's Hospital Anesthesiology
Specialties
Anesthesiology

Data Provided by:
Data Provided by:

Tips for Women at High Risk for Breast Cancer

Provided By:

FRIDAY, Dec. 4 (HealthDay News) -- Worries about side effects are a major reason why only 6 percent of American women at high risk for breast cancer are willing to take the drug tamoxifen to prevent the disease, a new study finds.

In an effort to inform women about the risks and benefits of tamoxifen, researchers at the University of Michigan Comprehensive Cancer Center created a decision aid, which was tailored to the health history of each of the 632 women in the study.

"That means, when women read this decision aid, they learned about how the drug was likely to affect them given their age, race, breast cancer history and medical history," study author Angela Fagerlin, an associate professor of internal medicine at the University of Michigan Medical School and a research investigator at the VA Ann Arbor Healthcare System, said in a university news release.

The researchers found that the decision aid helped inform the women about the risks and benefits of tamoxifen, with 63 percent correctly answering at least five of the six questions about the drug and 41 percent getting all six questions right.

However, although the women apparently achieved a high level of understanding about the risks and benefits of tamoxifen therapy, only 29 percent said they were likely to look for more information about the drug, 29 percent said they'd talk to their doctor about it and only 6 percent said they were likely to take tamoxifen. When questioned about the drug again three months later, fewer than 1 percent of the women had started taking the drug and fewer than 6 percent had sought more information or talked to their doctor about tamoxifen.

Eighty percent of the women in the study said they were worried about the drug's side effects, which can include hot flashes, sexual problems and, in rare cases, blood clots, cataracts or endometrial cancer, the study authors noted.

"Experts have bemoaned the dearth of women taking these pills, worried that word has not gotten out about tamoxifen's ability to prevent breast cancer in high-risk women. Our study shows that even when the word does get out, most women are too concerned about the pills' side effects to want to take it," senior author Dr. Peter Ubel, a professor of internal medicine and director of the University of Michigan's Center for Behavioral and Decision Sciences in Medicine, said in the news release.

The study was released online in advance of publication in an upcoming print issue of the journal Breast Cancer Research and Treatment.

More information

The U.S. National Cancer Institute has more about tamoxifen.

SOURCE: University of Michigan, news release, Dec. 3, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com